|
演讲嘉宾 |
|
 |
chen xiaoxiang vice president, medicine r&d, boehringer ingelheim china/hong kong/taiwan |
|
 |
shen huaqiong chief medical officer, jiangsu hengrui medicine co. ltd |
|
 |
yu qin legal specialist, r&d legal division, asia pacific, pfizer |
|
 |
qiang shengzhen site contract leader, parexel international |
|
 |
li huafang excutive director, chinaaro-p pi, gcp platform, science and technology national major project for ind director, mict, shanghai mental health center |
|
|
|